IBM’s Watson Analytics: How IBM Watson will impact our fight against Cancer
Reporter: Aviva Lev-Ari, PhD, RN
In the initial phase of the program, participating organizations will apply Watson to analyze the genomic data of patients who are battling all types of cancer, including lymphoma, melanoma, pancreatic, ovarian, brain, lung, breast and colorectal cancer. In cases where surgery, chemotherapy or radiation treatment have failed, these cancer patients could benefit from isolating treatments that target their specific cancer-causing genetic mutations. The collaborations at these institutions — including
- New York Genome Center,
- McDonnell Genome Institute at Washington University in St. Louis,
- University of North Carolina Lineberger Cancer Center and
- Yale Cancer Center —
will enable clinicians to use Watson with an expanded set of patients by the end of 2015.
[The incredible potential and dangers of data mining health records]
VIEW VIDEO
SOURCE
Leave a Reply